Yednock T A, Cannon C, Vandevert C, Goldbach E G, Shaw G, Ellis D K, Liaw C, Fritz L C, Tanner L I
Athena Neurosciences, Inc., South San Francisco, California 94080, USA.
J Biol Chem. 1995 Dec 1;270(48):28740-50. doi: 10.1074/jbc.270.48.28740.
alpha 4 beta 1 integrin (VLA-4) appears to be unique among the leukocyte integrins in that it can initiate the adhesion of circulating lymphocytes without cellular activation. It is not known how lymphocytes or other cell types maintain constitutive levels of alpha 4 beta 1 integrin activity. The current report describes a monoclonal antibody, 15/7, that recognizes a high affinity or ligand-occupied conformation of beta 1 integrin. Studies with 15/7 revealed that alpha 4 beta 1 integrin-dependent adhesion of leukocytic cell lines is mediated by a population of low affinity receptors that is conformationally responsive to ligand; the 15/7 epitope could be induced by nanomolar concentrations of soluble VCAM-1 or by micromolar concentrations of a peptide derived from the type III connecting segment domain of fibronectin (as ligands for alpha 4 beta 1 integrin). The same receptors were also responsive to adhesion activating reagents, such as Mn2+, activating anti-beta 1 integrin antibodies, and phorbol myristate acetate, which induced the 15/7 epitope directly and/or decreased the concentration of ligand required for epitope induction. In addition to the responsive receptor pool, cells expressed a second population of alpha 4 beta 1 integrin that was conformationally restrained, failing to respond to ligand or to any of the activating reagents. The relative size of the responsive and inactive receptor pools, as well as the affinity of the responsive receptors, represented a stable phenotype of different cell types and played important roles in defining the cells' adhesive capacity and ligand specificity. Similar receptor populations were measured on lymphocyte subsets in whole blood. These studies provide insight into how cells maintain different constitutive levels of alpha 4 beta 1 integrin activity, and how the activity of beta 1 integrin can be modulated by activators of cell adhesion.
α4β1整合素(VLA - 4)在白细胞整合素中似乎是独特的,因为它能够在没有细胞活化的情况下启动循环淋巴细胞的黏附。目前尚不清楚淋巴细胞或其他细胞类型如何维持α4β1整合素活性的组成水平。本报告描述了一种单克隆抗体15/7,它识别β1整合素的高亲和力或配体占据的构象。用15/7进行的研究表明,白细胞细胞系中α4β1整合素依赖性黏附是由一群低亲和力受体介导的,这些受体对配体具有构象反应性;纳摩尔浓度的可溶性VCAM - 1或微摩尔浓度的源自纤连蛋白III型连接段结构域的肽(作为α4β1整合素的配体)可诱导15/7表位。相同的受体也对黏附激活剂有反应,如Mn2 +、激活抗β1整合素抗体和佛波酯肉豆蔻酸酯乙酸酯,它们直接诱导15/7表位和/或降低表位诱导所需的配体浓度。除了反应性受体库外,细胞还表达了第二群α4β1整合素,其构象受到限制,对配体或任何激活剂均无反应。反应性和无活性受体库的相对大小以及反应性受体的亲和力代表了不同细胞类型的稳定表型,并在定义细胞的黏附能力和配体特异性方面发挥重要作用。在全血中的淋巴细胞亚群上也检测到了类似的受体群体。这些研究为细胞如何维持α4β1整合素活性的不同组成水平以及β1整合素的活性如何被细胞黏附激活剂调节提供了深入了解。